Sodium triacetoxyborohydride → (+/-)-6-({[(trans-4-fluoro-1-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]amino}methyl)-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one
Reaction equation
[F:1][C@@H:2]1[CH2:6][N:5]([CH2:7][CH2:8][C:9]2[C:18]3[C:13](=[CH:14][CH:15]=[C:16]([O:19][CH3:20])[N:17]=3)[N:12]=[CH:11][C:10]=2[F:21])[CH2:4][C@H:3]1[CH2:22][NH2:23].[O:24]=[C:25]1[NH:30][C:29]2[N:31]=[C:32]([CH:35]=O)[CH:33]=[CH:34][C:28]=2[S:27][CH2:26]1.[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+]>C(Cl)Cl.CCO>[F:1][C@@H:2]1[CH2:6][N:5]([CH2:7][CH2:8][C:9]2[C:18]3[C:13](=[CH:14][CH:15]=[C:16]([O:19][CH3:20])[N:17]=3)[N:12]=[CH:11][C:10]=2[F:21])[CH2:4][C@H:3]1[CH2:22][NH:23][CH2:35][C:32]1[CH:33]=[CH:34][C:28]2[S:27][CH2:26][C:25](=[O:24])[NH:30][C:29]=2[N:31]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
To a stirred solution of (±)-[(trans-4-fluoro-1-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]amine (0.25 g, 0.77 mmole) in dry CH2Cl2 (25 mL) and dry EtOH (10 mL) at RT was added 3-oxo-3,4-dihydro-2H-pyrido[1,4]thiazine-6-carboxaldehyde (0.15 g, 0.77 mmole). After 24 h, at RT was added NaBH(OAc)3 (0.24 g, 1.15 mmole). After 2 h, the reaction solution was concentrated under vacuum and purified on silica (CHCl3/MeOH, 9:1 containing 5% NH4OH) to afford the title compound (0.23 g, 60%) as light yellow solid: 1H NMR (400 MHz, CD3OD) δ 8.75 (s, 1H), 8.25 (d, J=9.1 Hz, 1H), 7.83 (d, J=7.8 Hz, 1H), 7.25 (d, J=9.1 Hz, 1H), 7.15 (d, J=7.8 Hz, 1H), 4.43 (s, 2H), 4.19 (s, 3H), 3.90 (m, 2H), 3.77 (m, 4H), 3.65 (m, 4H), 3.57 (m, 2H), 3.32 (app s, 2H). LC-MS (ES) m/e 501 (M+H)+.
Workup
- waitAfter 2 h
- concentrationthe reaction solution was concentrated under vacuum
- custompurified on silica (CHCl3/MeOH, 9:1 containing 5% NH4OH)
Sources & evidence
- ORD record
- ord-562d37f0361c443ea40ea996727805eb
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07691850B2
Reaction notes
Loading…